Safety and feasibility assessment of extending the flushing interval in totally implantable venous access port flushing during the non-treatment stage for patients with breast cancer

HIGHLIGHTS

• who: Yinhuan Wang from the Nanjing Medical University, China have published the research: Safety and feasibility assessment of extending the flushing interval in totally implantable venous access port flushing during the non-treatment stage for patients with breast cancer, in the Journal: (JOURNAL)
• what: Most of the research on extending the TIVAP flushing interval has focused on patients with gastrointestinal tumors, lung cancer, gynecologic tumors, and hematologic malignancies, with only a few studies exclusively focusing on extending the TIVAP flushing interval in patients with BC. The authors conducted a retrospective analysis to explore the adverse . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.